Condition: Persistent Asthma
Interventions: Drug: Fluticasone propionate Multidose Dry Powder Inhaler (Fp MDPI); Drug: Fluticasone propionate /salmeterol MDPI (FS MDPI); Drug: Fluticasone propionate HFA Inhalation Aerosol; Drug: Fluticasone propionate/salmeterol dry powder formulation
Sponsors: Teva Pharmaceutical Industries; Teva Branded Pharmaceutical Products, R&D Inc.
Recruiting – verified June 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days